Works matching IS 20506511 AND DT 2025 AND VI 26 AND IP 1

Results: 90

Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024).

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00920-4

By:

Yang, Yang;
Cui, Zhiwei;
Feng, Xiaoshan;
Zou, Fan;
Wu, Xiaoling

Publication type:

Article

Integrative analysis reveals key molecular mechanisms and prognostic model for Ethylnitrosourea-induced gliomagenesis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00919-x

By:

Tan, Bo;
Chen, Tao;
Song, Peng;
Lin, Feng;
He, Shuangyin;
Zhang, Shiyuan;
Yin, Xiaohong

Publication type:

Article

Quercetin-mediated restoration of high-fat diet-induced male reproductive dysfunction through modifying spermatogenesis and unraveling 3β-HSD, 17β-HSD, and StAR pathways.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00918-y

By:

Hafez, Mona H.;
Gad, Shereen B.;
El-Sayed, Yasser S.

Publication type:

Article

A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS).

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00927-x

By:

Xiong, Xiaomei;
Zhang, Xiuwen;
Tang, Fengmin;
Huang, Taomin

Publication type:

Article

Identification of key therapeutic targets in nicotine-induced intracranial aneurysm through integrated bioinformatics and machine learning approaches.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00921-3

By:

Ma, Qiang;
Zhou, Longnian;
Li, Zhongde

Publication type:

Article

Trimetazidine effect on kidney function in patients undergoing coronary procedures.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00913-3

By:

Abdel-Hady, Yasser;
Taha, Mohammed;
El Barbary, Ahmed;
Amin, Osama

Publication type:

Article

Sevoflurane reduces cardiomyocyte injury in a hypoxia/reoxygenation model of cardiomyocytes through the linc01278/miR-134-5pt regulatory axis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00909-z

By:

Wang, Ling;
Zhu, Changhua;
Shao, Yangge;
Chen, Rui;
Liang, Hui

Publication type:

Article

Zinc sulphate attenuates metabolic dysfunctions induced by olanzapine via the reduction of insulin resistance, hepatic oxidative stress, and inflammation in albino rats.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00889-0

By:

Bashandy, Samir A. E.;
Mostafa, Rasha E.;
El-Baset, Marawan A.;
Ibrahim, Fatma A. A.;
Morsy, Fatma A.;
Farid, Omar A.;
Ibrahim, Halima M.;
Mohamed, Bassim M. S. A.

Publication type:

Article

Can vildagliptin protect against radiation-induced premature ovarian failure? Insights into the AMPK and AKT signaling pathways.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00903-5

By:

Mahgoub, Nada A.;
El-Sherbiny, Doaa A.;
El-Demerdash, Ebtehal

Publication type:

Article

Safety profile of faricimab: a multi-source pharmacovigilance analysis using FAERS and JADER.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00902-6

By:

Liu, Chuanya;
Li, Shangze;
Wang, Ziyi;
Li, Zhifu;
Fang, Zhou;
Zhang, Yuan;
Gao, Yu

Publication type:

Article

Commentary on "real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies".

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00923-1

By:

Namdar, Ali Beheshti;
Keikha, Masoud

Publication type:

Article

Saikosaponin D inhibits the inflammatory response of secretory otitis media through FTO-mediated N<sup>6</sup>-methyladenosine modification of TLR4 mRNA.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00910-6

By:

Yin, Minjing;
Han, Xiuli

Publication type:

Article

Modified diatom-based ocular suspension for sustained diclofenac sodium delivery: a novel drug carrier approach.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00917-z

By:

Ghasemi Shayan, Ramin;
Jalaei, Dorsa;
Dobakhti, Faramarz

Publication type:

Article

Comparison of the efficacy of sucroferric oxyhydroxide and lanthanum carbonate in the hyperphosphatemia of maintainable Hemodialysis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00914-2

By:

Li, Min;
Kang, YiJing;
Zhang, Chao;
Ni, XiQuan

Publication type:

Article

Kaempferol inhibits cardiomyocyte pyroptosis via promoting O-GlcNAcylation of GSDME and improved acute myocardial infarction.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00908-0

By:

Zhou, Jie;
Zhou, Huifei;
Zhu, Jianfeng;
Fang, Shunjin

Publication type:

Article

Development and validation of simple colorimetric methods for assessing norfloxacin in pure form, in pharmaceutical products and in biological material.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00916-0

By:

Khan, Muhammad Naeem;
Adnan, Muhammad;
Bibi, Nusrat;
Kamal, Asif;
Mustafa, Abd El-Zaher M. A.;
Ali, Iftikhar

Publication type:

Article

A retrospective research of adverse event reporting system events for voxelotor based on the FAERS database.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00915-1

By:

Lin, Ying;
Li, Hua;
Dong, Yuqing;
Fang, Weiyue;
Huang, He;
He, Muqing;
Zhou, Xiaohai;
Sun, Ni

Publication type:

Article

Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00912-4

By:

Qu, Yaxin;
Wang, Shuxin;
Xie, Hanzhang;
Meng, Xiao;
Cui, Bingnan;
Xiao, Zhanshuo

Publication type:

Article

Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00911-5

By:

Tu, Jiakuan;
Zhang, Chaoxiang;
Qiu, Yichun;
Zhang, Hao;
Zheng, Jiaxin;
Xie, Shuihua;
He, Jianhua

Publication type:

Article

Protective effects of lipid emulsion on vital organs through the LPS/TLR4 pathway in acute organophosphate poisoning.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00904-4

By:

Li, Gang;
Hu, Haiyan

Publication type:

Article

AMD1, a cardiotoxicity target for Maduramicin.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00897-0

By:

Xie, Zi-Feng;
Liu, Han-Meng;
Zhao, Jia-Fan;
Gao, Yuan;
Zhao, Yuan-Long;
Zheng, Jia-Yue;
Pei, Xiao-Wei;
Zhang, Ning;
Tian, Ge

Publication type:

Article

Post-market safety profile of cefiderocol: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS).

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00894-3

By:

Lin, Hao;
Zhu, Chen;
Liu, Shuang;
Bi, Yingmin;
Hu, Jindong;
Ju, Mohan

Publication type:

Article

Post-marketing safety of elacestrant in breast cancer: a pharmacovigilance investigation using the FDA adverse event reporting system.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00887-2

By:

Fan, Ziyi;
Xu, Yanan;
Guo, Shuding;
Song, Bin

Publication type:

Article

Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00886-3

By:

Mu, Li;
Xu, Jing;
Ye, Xiaomei;
Jiang, Yongxian;
Yi, Zhanmiao

Publication type:

Article

Effects of different antiplatelet therapy drugs on platelet activation and platelet-leukocyte aggregate formation in early septic ARDS.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-024-00806-x

By:

Wang, Lu;
Mi, Liang-yu;
Chen, Xiang-yu;
He, Huai-Wu;
Long, Yun

Publication type:

Article

Mitigating hepatic ischemia and reperfusion injury with polyethylene glycol-enriched Ringer's lactate fluid: insights from an isolated perfused rat model.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00835-0

By:

Jeddou, Ikram Ben;
Zaouali, Mohamed Amine;
Chaabani, Roua;
Belgacem, Sameh;
Cherif, Amira;
Ben Abdennebi, Hassen

Publication type:

Article

Can quercetin reduce arsenic induced toxicity in mouse BALB/c 3T3 fibroblast cells? A study involving in vitro, molecular docking, and ADME predictions.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00906-2

By:

Unsal, Velid;
Keskin, Cumali;
Oner, Erkan

Publication type:

Article

Effects of adenosine triphosphate, thiamine pyrophosphate, melatonin, and liv-52 on subacute pyrazinamide proliferation hepatotoxicity in rats.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00901-7

By:

Ciftel, Sedat;
Ciftel, Serpil;
Altuner, Durdu;
Huseynova, Gulbaniz;
Yucel, Nurinisa;
Mendil, Ali Sefa;
Sarigul, Cengiz;
Suleyman, Halis;
Bulut, Seval

Publication type:

Article

Combination of 10-hydroxy-decanoic acid and ZnO nanoparticles abrogates lead acetate-induced nephrotoxicity in rats: targeting oxidative stress and inflammatory signalling.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00888-1

By:

Saleh, Samar R.;
Agwah, Raheel G.;
Elblehi, Samar S.;
Ghareeb, Ahmed Z.;
Ghareeb, Doaa A.;
Maher, Adham M.

Publication type:

Article

Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013–2022).

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00905-3

By:

Zhang, Jianxiong;
Wu, Jingxuan;
Li, Jiangshuo;
Liu, Meixia;
Liu, Shaodan;
He, Ruirui;
Dong, Ruihua

Publication type:

Article

Development and validation of potential molecular subtypes and signatures of thyroid eye disease based on angiogenesis-related gene analysis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00880-9

By:

Wu, Zixuan;
Peng, Jun;
Long, Xi;
Tan, Kang;
Yao, Xiaolei;
Peng, Qinghua

Publication type:

Article

Oxidative stress and anti-oxidant status in children with sepsis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00895-2

By:

Arı, Hatice Feray;
Arı, Murat;
Ogut, Serdal

Publication type:

Article

Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00884-5

By:

Jiang, Puen;
Zong, Kezhen;
Peng, Dadi;
Zhou, Baoyong;
Wu, Zhongjun

Publication type:

Article

A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS).

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00890-7

By:

Xue, ZeHu;
Liu, Xi;
Liu, QiFeng;
Yang, XiuMing;
Yu, LiXia

Publication type:

Article

A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00896-1

By:

Yang, Zhuan;
Li, Qin;
Yu, Danfeng;
Zhang, Xiaojuan;
Wang, Ying;
Liu, Shijing;
Chen, Lu;
Zhou, Yan;
Zeng, Chen;
Zeng, Yan;
Cai, Chen;
Xiong, Yun;
Zhang, Qian;
Li, Na;
Du, Peng;
Liu, Lin;
Chen, Jiyu;
He, Yan

Publication type:

Article

A new RP-HPLC approach for estimation of potential impurities of Fosamprenavir - method development and validation.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00892-5

By:

Godela, Ramreddy;
Nelson, Vinod Kumar;
Nuli, Mohana Vamsi;
Jaini, Pavan Kumar;
Pathak, Shilpi;
Ponnekanti, Krishnaphanisri;
Suryadevara, Punna Rao;
Burle, Gowri Sankararao;
Mayasa, Vinyas;
Kesari, Kavindra Kumar

Publication type:

Article

Adverse event profile of crizotinib in real-world from the FAERS database: a 12-year pharmacovigilance study.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00859-6

By:

Zhang, Huan;
Song, Yunrui;
Xia, Fantong;
Liu, Yunchang;
Zhang, Lu;
Yang, Jieying;
Tu, Honglei;
Long, Bin;
Sui, Jiangdong;
Wang, Ying

Publication type:

Article

Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00898-z

By:

Fan, Xingyu;
Wang, Yueyue;
Wang, Yue;
Duan, Hao;
Du, Yijun;
Pan, Tianrong;
Zhong, Xing

Publication type:

Article

Therapeutic role of melatonin on acrylamide-induced neurotoxicity via reducing ER stress, inflammation, and apoptosis in a rat model.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00900-8

By:

Dag, Yusuf;
Yildirim, Serkan;
Sengul, Emin;
Aykurt, Furkan;
Gok, Melahat;
Cinar, Ali

Publication type:

Article

Correction: Aspirin plus clopidogrel versus cilostazol -based triple antiplatelet therapy in patients with ischemic heart disease undergoing PCI: a systematic review and meta-analysis of randomized controlled trials.

Published in:

2025

By:

Odat, Ramez M.;
Ahmed, Mushood;
Alshwayyat, Sakhr;
Hussein, Ayham Mohammad;
AlSaraireh, Taif Haitham;
Molhem, Ahmad M.;
Aldamen, Ali O.;
Ababneh, Malak;
Quwaider, Bishr;
Jain, Hritvik;
Yasin, Jehad A.;
Hanifa, Hamdah;
Ahmed, Raheel

Publication type:

Correction Notice

A disproportionality analysis of real-world events from the FDA Adverse Event Reporting System (FAERS) for Atezolizumab.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00879-2

By:

Li, Zhuoyang;
Zhu, Ning;
Liu, Yuwei;
Yu, Yan;
Wang, Tianhong;
Zou, Congcong;
Wang, Siman;
Ou, Xiaofeng

Publication type:

Article

Computational study on the mechanism of small molecules inhibiting NLRP3 with ensemble docking and molecular dynamic simulations.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00851-0

By:

Qin, Pingyang;
Niu, Yuzhen;
Duan, Jizheng;
Lin, Ping

Publication type:

Article

Development of nanospray loaded with ciclopirox for dermal fungus treatment: determination of pro-inflammatory interleukin IL-2 mRNA expression.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00853-y

By:

Mehmood, Yasir;
Shahid, Hira;
Nazir, Rabbia;
Uddin, Mohammad N.;
Nur-e-Alam, Mohammad;
Bourhia, Mohammed;
Almaary, Khalid S.;
Kazi, Mohsin;
Mahamat, Ousman B.

Publication type:

Article

Safety analysis of romiplostim, eltrombopag, and avatrombopag post-market approval: a pharmacovigilance study based on the FDA Adverse Event Reporting System.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00873-8

By:

Wang, Xiaoling;
Li, Yunsong;
Zhuang, Wei

Publication type:

Article

Risk of drug-induced pericardial effusion: a disproportionality analysis of the FAERS database.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00867-6

By:

Ren, Gaocan;
Huang, Pingping;
Ding, Yanqiu;
Ma, Xiaochang

Publication type:

Article

Gastrointestinal toxicity of antibody–drug conjugates: a pharmacovigilance study using the FAERS database.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00877-4

By:

Shi, Yanshuo;
Yao, Kaiqing;
Zhao, Jianqun;
Yue, Yuanyuan;
Wu, Huizhen

Publication type:

Article

A comparative study of using scorpion antivenom versus scorpion antivenom and prazosin drug for scorpion stings management in Sohag University Hospitals.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00854-x

By:

Shokry Zaghary, Meray Medhat;
Abd ElKader, Mai Mostafa

Publication type:

Article

Haemorrhage-related adverse events profles of lenvatinib and pembrolizumab alone or in combination: a real-world pharmacovigilance study based on FAERS database.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00878-3

By:

Wang, Shiqiao;
Ren, Guizhi;
Pan, Heng;
Chen, Jiayi;
Huang, Jiayu;
Mei, Qinghua;
Li, Zhongze;
Zou, Guosheng

Publication type:

Article

Prodelphinidin B-2,3,3"-O-gallate via chemical oxidation of epigallocatechin-3-gallate shows high efficacy inhibiting triple-negative breast cancer cells.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00883-6

By:

Wang, Jing;
Wang, Yuna;
Zhang, Shuanggou;
Hu, Hongtao;
Zhang, Ruohan;
Zi, Chengting;
Sheng, Jun;
Sun, Peiyuan

Publication type:

Article

Past use of metformin is associated with increased risk of myelodysplastic syndrome development in diabetes mellitus patients: a cross-sectional study of 54,869 patients.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00882-7

By:

Hellou, Tamer;
Dumanis, Guy;
Portugez, Shir;
Goncharov, Aviv Philip;
Trodler, Eden;
Stern, Asaf;
Carlebach, Imanuel;
Kahlon, Omer;
Jwella, Maysan Abu;
Nimer, Ekram;
Athamna, Ahlam;
Berman, Aya;
Segal, Gad;
Lerner, Reut Kassif

Publication type:

Article